Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Black–White disparities across the colorectal cancer care continuum in the USA

Abstract

Colorectal cancer (CRC) remains a substantial public health challenge globally and is the second leading cause of cancer-related death in the USA. Despite advances in screening and treatment, disparities in CRC outcomes persist, especially among Black individuals in the USA, who face higher CRC incidence and mortality and lower survival compared with White individuals. Inequities are largely attributed to social determinants of health (SDOH), such as access to health care, socioeconomic conditions and systemic inequities. In this Review, we examine Black–White disparities in CRC outcomes across the CRC care continuum in the USA, highlighting contributing modifiable (non-biological) and non-modifiable (biological) risk factors. We also discuss successful interventions that have reduced or eliminated disparities. Existing evidence suggests that Black–White differences in CRC screening participation, CRC incidence and CRC mortality can be resolved. Future efforts must emphasize improving access to screening and guideline-concordant treatment to achieve progress in the near term while addressing the underlying and historical SDOH that drive inequities to eliminate disparities in the long term. The Review underscores the need for sustained investment in addressing both immediate and systemic barriers to CRC screening and care in Black communities to eliminate disparities in CRC outcomes and improve the overall health of the nation.

Key points

  • Colorectal cancer (CRC) disproportionately affects Black individuals in the USA, who experience higher incidence and mortality, and lower survival rates than White individuals despite an overall decline in incidence.

  • Social determinants of health (SDOH) are structural, economic, social and environmental factors that drive disparities in CRC outcomes by affecting access to health care, participation in screening and receipt of timely, high-quality care.

  • Modifiable CRC risk factors that result from adverse SDOH and contribute to inequities include medical comorbidities more common in Black individuals, low participation in CRC screening and low receipt of guideline-concordant treatment.

  • There are limited data supporting biological factors as drivers of disparities, and observed Black–White biological differences in CRC outcomes are probably influenced by mechanisms through which social factors affect health.

  • Successful interventions that target SDOH and modifiable risk factors, such as screening participation, demonstrate that the reduction and elimination of Black–White disparities in CRC screening and CRC outcomes are achievable.

  • A dual approach focusing on near-term improvements in access to screening and care and long-term interventions addressing SDOH is essential to eliminate Black–White inequities in CRC outcomes and to reduce the overall effect of CRC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Social determinants of health for CRC screening and outcomes.
Fig. 2: Trends in incidence rates for CRC, colon cancer and rectum cancer in Black and White individuals in the USA, 1975–2019, SEER 8 registries.
Fig. 3: Trends in CRC death rates for Black and White individuals in the USA, 1969–2022.
Fig. 4: Trends in 5-year overall survival rates for Black and White individuals in the USA by stage, 1975–1981, 1992–1998 and 2013–2019.
Fig. 5: State variation in CRC death rates by state and race in the USA, 2018–2022.
Fig. 6: Black-to-White CRC mortality rate ratio ranked by US state, 2018–2022.

Similar content being viewed by others

Data availability

Databases referred to in Fig. 2 can be accessed from the Surveillance, Epidemiology, and End Results (SEER) 8 registries program (https://seer.cancer.gov/data). Databases referred to in Figs. 3, 5 and 6 can be accessed from the National Cancer Institute mortality database (https://seer.cancer.gov/mortality). Databases referred to in Fig. 4 can be accessed from the SEER 8 areas for 1975–1981 and SEER 12 areas for 1992–1998 and 2013–2019 (https://seer.cancer.gov/data).

References

  1. Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).

    PubMed  Google Scholar 

  2. GBD 2019 Colorectal Cancer Collaborators Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global burden of disease study 2019. Lancet Gastroenterol. Hepatol. 7, 627–647 (2022); erratum 7, 704 (2022).

    Article  Google Scholar 

  3. Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233–254 (2023).

    PubMed  Google Scholar 

  4. Gupta, S., May, F. P., Kupfer, S. S. & Murphy, C. C. Birth cohort colorectal cancer (CRC): implications for research and practice. Clin. Gastroenterol. Hepatol. 22, 455–469.e7 (2024).

    Article  PubMed  Google Scholar 

  5. Alsakarneh, S. et al. Disparities in colorectal cancer incidence in the United States, 2000-2019. Gastro Hep Adv. 3, 562–564 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Carethers, J. M. & Doubeni, C. A. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology 158, 354–367 (2020).

    Article  PubMed  Google Scholar 

  7. Lorentsen, M. K. & Sanoff, H. K. Social determinants of health and the link to colorectal cancer outcomes. Curr. Treat. Options Oncol. 25, 453–464 (2024).

    Article  PubMed  Google Scholar 

  8. Zauber, A. G. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig. Dis. Sci. 60, 681–691 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Schneider, M. Census data: US is diversifying, white population shrinking. Associated Press https://apnews.com/article/race-and-ethnicity-census-2020-7264a653037e38df7ba67d3a324fc90d (2021).

  10. Braveman, P. A. et al. Health disparities and health equity: the issue is justice. Am. J. Public Health 101, S149–S155 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Commission on Social Determinants of Health. Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health (WHO, 2008).

  12. Dahlgren, G. & Whitehead, M. Policies and Strategies to Promote Social Equity in Health. Background Document to WHO — Strategy Paper for Europe (Institute for Futures Studies, 1991).

  13. Solar, O. & Irwin A. A Conceptual Framework for Action on the Social Determinants of Health. Social Determinants of Health Discussion Paper 2 (Policy and Practice) (WHO, 2010).

  14. Bharmal, N., Derose, K. P., Felician, M. F. & Weden, M. M. Understanding the upstream social determinants of health. RAND https://www.rand.org/pubs/working_papers/WR1096.html (2015).

  15. Thimm-Kaiser, M., Benzekri, A. & Guilamo-Ramos, V. Conceptualizing the mechanisms of social determinants of health: a heuristic framework to inform future directions for mitigation. Milbank Q. 101, 486–526 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (eds Smedley, B. D., Stith, A. Y. & Nelson, A. R.) (National Academies, 2003).

  17. Giaquinto, A. N. et al. Cancer statistics for African American/Black people 2022. CA Cancer J. Clin. 72, 202–229 (2022).

    PubMed  Google Scholar 

  18. Brown, M. L. & Potosky, A. L. The presidential effect: the public health response to media coverage about Ronald Reagan’s colon cancer episode. Public Opin. Q. 54, 317–329 (1990).

    Article  CAS  PubMed  Google Scholar 

  19. Jepson, C., Kessler, L. G., Portnoy, B. & Gibbs, T. Black–white differences in cancer prevention knowledge and behavior. Am. J. Public Health 81, 501–504 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Chu, K. C., Tarone, R. E., Chow, W. H. & Alexander, G. A. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch. Fam. Med. 4, 849–856 (1995).

    Article  CAS  PubMed  Google Scholar 

  21. Cram, P. et al. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch. Intern. Med. 163, 1601–1605 (2003).

    Article  PubMed  Google Scholar 

  22. Doubeni, C. A. et al. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am. J. Prev. Med. 38, 184–191 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kahlam, A., Chowdhury, S., Kahlam, J., Amer, K. & Ahlawat, S. The Boseman effect: a missed opportunity? Cureus 14, e24959 (2022).

    PubMed  PubMed Central  Google Scholar 

  24. Cohen, S. A., Nash, C. C., Byrne, E. N., Mitchell, L. E. & Greaney, M. L. Black/White disparities in obesity widen with increasing rurality: evidence from a national survey. Health Equity 6, 178–188 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Thompson, T. L., Singleton, C. R., Springfield, S. E., Thorpe, R. J. Jr. & Odoms-Young, A. Differences in nutrient intake and diet quality between non-Hispanic black and non-Hispanic white men in the United States. Public Health Rep. 135, 334–342 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tao, M. H., Liu, J. L. & Nguyen, U. D. T. Trends in diet quality by race/ethnicity among adults in the United States for 2011-2018. Nutrients 14, 4178 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Davis, J. S. et al. Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic. Open Heart 4, e000550 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  28. Zhang, J. et al. Effectiveness of screening modalities in colorectal cancer: a network meta-analysis. Clin. Colorectal Cancer 16, 252–263 (2017).

    PubMed  Google Scholar 

  29. Kahi, C. J. et al. Colonoscopy and colorectal cancer mortality in the Veterans Affairs health care system: a case-control study. Ann. Intern. Med. 168, 481–488 (2018).

    Article  PubMed  Google Scholar 

  30. Koyama, A. K. et al. Prevalence of cardiometabolic diseases among racial and ethnic subgroups in adults — behavioral risk factor surveillance system, United States, 2013–2021. MMWR Morb. Mortal. Wkly Rep. 73, 51–56 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yothers, G. et al. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J. Natl Cancer Inst. 103, 1498–1506 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  32. Murphy, N. et al. Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: a multinational cohort study. Clin. Gastroenterol. Hepatol. 17, 1323–1331.e6 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wang, L. et al. Risk factor profiles differ for cancers of different regions of the colorectum. Gastroenterology 159, 241–256.e13 (2020).

    Article  PubMed  Google Scholar 

  34. Ugai, T. et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat. Rev. Clin. Oncol. 19, 656–673 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  35. Saraiva, M. R., Rosa, I. & Claro, I. Early-onset colorectal cancer: a review of current knowledge. World J. Gastroenterol. 29, 1289–1303 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. [No authors listed] NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264, 1444–1450 (1990).

    Article  Google Scholar 

  37. Potosky, A. L., Harlan, L. C., Kaplan, R. S., Johnson, K. A. & Lynch, C. F. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J. Clin. Oncol. 20, 1192–1202 (2002).

    Article  PubMed  Google Scholar 

  38. Laiyemo, A. O. et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J. Natl Cancer Inst. 102, 538–546 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  39. Breslin, T. M. et al. Hospital factors and racial disparities in mortality after surgery for breast and colon cancer. J. Clin. Oncol. 27, 3945–3950 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  40. Star, J. et al. Updated review of major cancer risk factors and screening test use in the United States, with a focus on changes during the COVID-19 pandemic. Cancer Epidemiol. Biomark. Prev. 32, 879–888 (2023).

    Article  Google Scholar 

  41. Grubbs, S. S. et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J. Clin. Oncol. 31, 1928–1930 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  42. Naishadham, D., Lansdorp-Vogelaar, I., Siegel, R., Cokkinides, V. & Jemal, A. State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol. Biomark. Prev. 20, 1296–1302 (2011).

    Article  Google Scholar 

  43. Lauby-Secretan, B. et al. Body fatness and cancer – viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794–798 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  44. Ye, P., Xi, Y., Huang, Z. & Xu, P. Linking obesity with colorectal cancer: epidemiology and mechanistic insights. Cancers 12, 1408 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Ma, Y. et al. Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts. Br. J. Cancer 119, 1436–1442 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Wheat, C. L. et al. Worldwide incidence of colorectal cancer, leukemia, and lymphoma in inflammatory bowel disease: an updated systematic review and meta-analysis. Gastroenterol. Res. Pract. 2016, 1632439 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  47. Garland, C. F. et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2, 1176–1178 (1989).

    Article  CAS  PubMed  Google Scholar 

  48. Yang, T. et al. Work stress and the risk of cancer: a meta-analysis of observational studies. Int. J. Cancer 144, 2390–2400 (2019).

    Article  CAS  PubMed  Google Scholar 

  49. Lofton, H., Ard, J. D., Hunt, R. R. & Knight, M. G. Obesity among African American people in the United States: a review. Obesity 31, 306–315 (2023).

    Article  PubMed  Google Scholar 

  50. Parker, E. D. et al. Economic costs of diabetes in the U.S. in 2022. Diabetes Care 47, 26–43 (2024).

    Article  PubMed  Google Scholar 

  51. Cui, A. et al. Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001-2018. Front. Nutr. 9, 965376 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  52. Chida, Y., Hamer, M., Wardle, J. & Steptoe, A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat. Clin. Pract. Oncol. 5, 466–475 (2008).

    Article  PubMed  Google Scholar 

  53. Brown, L. L., Mitchell, U. A. & Ailshire, J. A. Disentangling the stress process: race/ethnic differences in the exposure and appraisal of chronic stressors among older adults. J. Gerontol. B Psychol. Sci. Soc. Sci. 75, 650–660 (2020).

    Article  PubMed  Google Scholar 

  54. Hatch, S. L. & Dohrenwend, B. P. Distribution of traumatic and other stressful life events by race/ethnicity, gender, SES and age: a review of the research. Am. J. Community Psychol. 40, 313–332 (2007).

    Article  PubMed  Google Scholar 

  55. Dahlhamer, J. M., Zammitti, E. P., Ward, B. W., Wheaton, A. G. & Croft, J. B. Prevalence of inflammatory bowel disease among adults aged ≥18 years – United States, 2015. MMWR Morb. Mortal. Wkly Rep. 65, 1166–1169 (2016).

    Article  PubMed  Google Scholar 

  56. Goonesekera, S. D., Dey, S., Thakur, S. & Davila, E. P. Racial/ethnic differences in autoimmune disease prevalence in US claims/EHR data. Am. J. Manag. Care 30, e4–e10 (2024).

    Article  PubMed  Google Scholar 

  57. Roshandel, G., Ghasemi-Kebria, F. & Malekzadeh, R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers 16, 1530 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  58. Fedirko, V. et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 22, 1958–1972 (2011).

    Article  CAS  PubMed  Google Scholar 

  59. McNabb, S. et al. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int. J. Cancer 146, 861–873 (2020).

    Article  CAS  PubMed  Google Scholar 

  60. Botteri, E. et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis. Am. J. Gastroenterol. 115, 1940–1949 (2020).

    Article  PubMed  Google Scholar 

  61. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Red Meat and Processed Meat (International Agency for Research on Cancer, 2018).

  62. Domingo, J. L. & Nadal, M. Carcinogenicity of consumption of red meat and processed meat: a review of scientific news since the IARC decision. Food Chem. Toxicol. 105, 256–261 (2017).

    Article  CAS  PubMed  Google Scholar 

  63. Mahmood, S., MacInnis, R. J., English, D. R., Karahalios, A. & Lynch, B. M. Domain-specific physical activity and sedentary behaviour in relation to colon and rectal cancer risk: a systematic review and meta-analysis. Int. J. Epidemiol. 46, 1797–1813 (2017).

    Article  PubMed  Google Scholar 

  64. Butler, L. M. et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am. J. Epidemiol. 157, 434–445 (2003).

    Article  CAS  PubMed  Google Scholar 

  65. Zhao, Z. et al. Red and processed meat consumption and colorectal cancer risk: a systematic review and meta-analysis. Oncotarget 8, 83306–83314 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  66. National Center for Chronic Disease Prevention and Health Promotion. Adult physical inactivity prevalence maps by race/ethnicity 2015–2018. CDC https://archive.cdc.gov/www_cdc_gov/physicalactivity/data/inactivity-prevalence-maps/2015-2018.html (2021).

  67. Creamer, M. R. et al. Tobacco product use and cessation indicators among adults – United States, 2018. MMWR Morb. Mortal. Wkly Rep. 68, 1013–1019 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  68. Office of the Surgeon General. Smoking Cessation: a Report of the Surgeon General (Department of Health and Human Services, 2020).

  69. Agaku, I. T., Odani, S., Okuyemi, K. S. & Armour, B. Disparities in current cigarette smoking among US adults, 2002-2016. Tob. Control 29, 269–276 (2020).

    PubMed  Google Scholar 

  70. Substance Abuse and Mental Health Services Administration. 2015 National Survey on Drug Use and Health: Detailed Tables (SAMHSA, 2016).

  71. Dawson, D. A., Goldstein, R. B., Saha, T. D. & Grant, B. F. Changes in alcohol consumption: United States, 2001–2002 to 2012–2013. Drug Alcohol Depend. 148, 56–61 (2015).

    Article  PubMed  Google Scholar 

  72. Malone, P. S., Northrup, T. F., Masyn, K. E., Lamis, D. A. & Lamont, A. E. Initiation and persistence of alcohol use in United States Black, Hispanic, and White male and female youth. Addict. Behav. 37, 299–305 (2012).

    Article  PubMed  Google Scholar 

  73. Colditz, G. A., Cannuscio, C. C. & Frazier, A. L. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control. 8, 649–667 (1997).

    CAS  PubMed  Google Scholar 

  74. Rezende, L. F. M. et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br. J. Sports Med. 52, 826–833 (2018).

    Article  PubMed  Google Scholar 

  75. Purdue, M. P. et al. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial (United States). Cancer Causes Control 16, 965–973 (2005).

    PubMed  Google Scholar 

  76. Chlebowski, R. T. et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N. Engl. J. Med. 350, 991–1004 (2004).

    Article  CAS  PubMed  Google Scholar 

  77. Kim, S. et al. Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans. Am. J. Epidemiol. 168, 1292–1300 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  78. Sansbury, L. B. et al. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am. J. Epidemiol. 162, 548–558 (2005).

    Article  PubMed  Google Scholar 

  79. Cifuentes, L. & O’Keefe, S. Analysis of 1999-2017 NHANES data: minimal increase and racial disparities in U.S. fiber consumption over 18 years. Nutr. Cancer 76, 345–351 (2024).

    Article  PubMed  Google Scholar 

  80. Alegria-Lertxundi, I., Bujanda, L. & Arroyo-Izaga, M. Role of dairy foods, fish, white meat, and eggs in the prevention of colorectal cancer: a systematic review of observational studies in 2018-2022. Nutrients 14, 3430 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Zhang, X. et al. Calcium intake and colorectal cancer risk: results from the Nurses’ Health Study and health professionals follow-up study. Int. J. Cancer 139, 2232–2242 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Jin, S. & Je, Y. Nuts and legumes consumption and risk of colorectal cancer: a systematic review and meta-analysis. Eur. J. Epidemiol. 37, 569–585 (2022).

    Article  PubMed  Google Scholar 

  83. Puzzono, M. et al. The role of diet and lifestyle in early-onset colorectal cancer: a systematic review. Cancers 13, 5933 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. International Agency for Research on Cancer. Vitamin D and Cancer. IARC Working Group Report Volume 5 (IARC, 2008).

  85. Hargreaves, M. K., Baquet, C. & Gamshadzahi, A. Diet, nutritional status, and cancer risk in American blacks. Nutr. Cancer 12, 1–28 (1989).

    Article  CAS  PubMed  Google Scholar 

  86. Christmas, M. et al. Menopause hormone therapy and complementary alternative medicine, quality of life, and racial/ethnic differences: the Study of Women’s Health Across the Nation (SWAN). Menopause 29, 1357–1364 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  87. Sanchez, N. F. et al. Physical activity reduces risk for colon polyps in a multiethnic colorectal cancer screening population. BMC Res. Notes 5, 312 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  88. Veettil, S. K. et al. Role of diet in colorectal cancer incidence: umbrella review of meta-analyses of prospective observational studies. JAMA Netw. Open 4, e2037341 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  89. Comerford, K. et al. The role of dairy food intake for improving health among black Americans across the life continuum: a summary of the evidence. J. Natl Med. Assoc. 116, 292–315 (2024).

    PubMed  Google Scholar 

  90. Conti, L., Del Corno, M. & Gessani, S. Revisiting the impact of lifestyle on colorectal cancer risk in a gender perspective. Crit. Rev. Oncol. Hematol. 145, 102834 (2020).

    Article  PubMed  Google Scholar 

  91. Anderson, L. M. & May, D. S. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am. J. Public Health 85, 840–842 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. May, F. P., Yang, L., Corona, E., Glenn, B. A. & Bastani, R. Disparities in colorectal cancer screening in the United States before and after implementation of the Affordable Care Act. Clin. Gastroenterol. Hepatol. 18, 1796–1804.e2 (2020).

    Article  PubMed  Google Scholar 

  93. Rao, S. R., Breen, N. & Graubard, B. I. Trends in black–white disparities in breast and colorectal cancer screening rates in a changing screening environment: the Peters–Belson approach using United States National Health Interview Surveys 2000-2010. Med. Care 54, 133–139 (2016).

    Article  PubMed  Google Scholar 

  94. Rutter, C. M., Knudsen, A. B., Lin, J. S. & Bouskill, K. E. Black and white differences in colorectal cancer screening and screening outcomes: a narrative review. Cancer Epidemiol. Biomark. Prev. 30, 3–12 (2021).

    Article  Google Scholar 

  95. Palaniappan, L. P. et al. Population colorectal cancer screening estimates: comparing self-report to electronic health record data in California. Int. J. Cancer Prev. 4, 28540 (2011).

    Google Scholar 

  96. Ferrante, J. M. et al. Self-report versus medical records for assessing cancer-preventive services delivery. Cancer Epidemiol. Biomark. Prev. 17, 2987–2994 (2008).

    Article  Google Scholar 

  97. Powe, B. D. & Cooper, D. L. Self-reported cancer screening rates versus medical record documentation: incongruence, specificity, and sensitivity for African American women. Oncol. Nurs. Forum 35, 199–204 (2008).

    Article  PubMed  Google Scholar 

  98. Zhao, M. Y. et al. Colorectal cancer screening rates at federally qualified health centers from 2014 to 2022: incomplete recovery from COVID-19 and worsening disparities. Am. J. Gastroenterol. 119, 1580–1589 (2024).

    Article  PubMed  Google Scholar 

  99. Ebner, D. W. et al. Trends in colorectal cancer screening from the National Health Interview Survey: analysis of the impact of different modalities on overall screening rates. Cancer Prev. Res. 17, 275–280 (2024).

    Article  CAS  Google Scholar 

  100. Zhu, X. et al. An examination of socioeconomic and racial/ethnic disparities in the awareness, knowledge and utilization of three colorectal cancer screening modalities. SSM Popul. Health 14, 100780 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  101. Inadomi, J. M. et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch. Intern. Med. 172, 575–582 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  102. Ruffin, M. T. T., Creswell, J. W., Jimbo, M. & Fetters, M. D. Factors influencing choices for colorectal cancer screening among previously unscreened African and Caucasian Americans: findings from a triangulation mixed methods investigation. J. Community Health 34, 79–89 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  103. Doubeni, C. A. et al. Association between improved colorectal screening and racial disparities. N. Engl. J. Med. 386, 796–798 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  104. Greiner, K. A., Born, W., Nollen, N. & Ahluwalia, J. S. Knowledge and perceptions of colorectal cancer screening among urban African Americans. J. Gen. Intern. Med. 20, 977–983 (2005).

    Article  PubMed  PubMed Central  Google Scholar 

  105. Bastani, R., Gallardo, N. V. & Maxwell, A. E. Barriers to colorectal cancer screening among ethnically diverse high- and average-risk individuals. J. Psychosoc. Oncol. 19, 65–84 (2008).

    Article  Google Scholar 

  106. Green, P. M. & Kelly, B. A. Colorectal cancer knowledge, perceptions, and behaviors in African Americans. Cancer Nurs. 27, 206–215 (2004).

    Article  PubMed  Google Scholar 

  107. Lipkus, I. M., Lyna, P. R. & Rimer, B. K. Colorectal cancer risk perceptions and screening intentions in a minority population. J. Natl Med. Assoc. 92, 492–500 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  108. Lipkus, I. M. et al. Colorectal screening patterns and perceptions of risk among African-American users of a community health center. J. Community Health 21, 409–427 (1996).

    Article  CAS  PubMed  Google Scholar 

  109. Anyane-Yeboa, A. et al. Use of a mixed-methods approach to develop a guidebook with messaging to encourage colorectal cancer screening among black individuals 45 and older. Cancer Med. 12, 19047–19056 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  110. Lasser, K. E., Ayanian, J. Z., Fletcher, R. H. & Good, M. J. Barriers to colorectal cancer screening in community health centers: a qualitative study. BMC Fam. Pract. 9, 15 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  111. Bromley, E. G., May, F. P., Federer, L., Spiegel, B. M. & van Oijen, M. G. Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review. Prev. Med. 71, 40–48 (2015).

    Article  PubMed  Google Scholar 

  112. Muthukrishnan, M., Arnold, L. D. & James, A. S. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev. Med. Rep. 15, 100896 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  113. Robillard, A. G. & Larkey, L. Health disadvantages in colorectal cancer screening among African Americans: considering the cultural context of narrative health promotion. J. Health Care Poor Underserved 20, 102–119 (2009).

    Article  PubMed  Google Scholar 

  114. White, P. M. & Itzkowitz, S. H. Barriers driving racial disparities in colorectal cancer screening in African Americans. Curr. Gastroenterol. Rep. 22, 41 (2020).

    Article  PubMed  Google Scholar 

  115. Roy, S. et al. Systematic review of interventions to increase stool blood colorectal cancer screening in African Americans. J. Community Health 46, 232–244 (2021).

    Article  PubMed  Google Scholar 

  116. Adams, L. B., Richmond, J., Corbie-Smith, G. & Powell, W. Medical mistrust and colorectal cancer screening among African Americans. J. Community Health 42, 1044–1061 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  117. Bass, S. B. et al. Perceptions of colorectal cancer screening in urban African American clinic patients: differences by gender and screening status. J. Cancer Educ. 26, 121–128 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  118. Hammond, W. P., Matthews, D., Mohottige, D., Agyemang, A. & Corbie-Smith, G. Masculinity, medical mistrust, and preventive health services delays among community-dwelling African-American men. J. Gen. Intern. Med. 25, 1300–1308 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  119. Lumpkins, C. Y. et al. Marketing a healthy mind, body, and soul: an analysis of how African American men view the church as a social marketer and health promoter of colorectal cancer risk and prevention. Health Educ. Behav. 43, 452–460 (2016).

    Article  PubMed  Google Scholar 

  120. Beeker, C., Kraft, J., Goldman, R. & Jorgensen, C. Strategies for increasing colorectal cancer screening among African Americans. J. Psychosoc. Oncol. 19, 113–132 (2001).

    Article  Google Scholar 

  121. Palmer, R. C., Midgette, L. A. & Dankwa, I. Colorectal cancer screening and African Americans: findings from a qualitative study. Cancer Control. 15, 72–79 (2008).

    Article  PubMed  Google Scholar 

  122. May, F. P., Almario, C. V., Ponce, N. & Spiegel, B. M. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening. Am. J. Gastroenterol. 110, 1388–1394 (2015).

    Article  PubMed  Google Scholar 

  123. Taylor, V. et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J. Natl Med. Assoc. 95, 806–812 (2003).

    PubMed  PubMed Central  Google Scholar 

  124. van Ryn, M. & Burke, J. The effect of patient race and socio-economic status on physicians’ perceptions of patients. Soc. Sci. Med. 50, 813–828 (2000).

    Article  PubMed  Google Scholar 

  125. Ge, G., Burke, N., Somkin, C. P. & Pasick, R. Considering culture in physician–patient communication during colorectal cancer screening. Qual. Health Res. 19, 778–789 (2009).

    Article  Google Scholar 

  126. Fyffe, D. C., Hudson, S. V., Fagan, J. K. & Brown, D. R. Knowledge and barriers related to prostate and colorectal cancer prevention in underserved black men. J. Natl Med. Assoc. 100, 1161–1167 (2008).

    PubMed  Google Scholar 

  127. Brandzel, S. et al. Latina and Black/African American women’s perspectives on cancer screening and cancer screening reminders. J. Racial Ethn. Health Disparities 4, 1000–1008 (2017).

    Article  Google Scholar 

  128. Xierali, I. M. & Nivet, M. A. The racial and ethnic composition and distribution of primary care physicians. J. Health Care Poor Underserved 29, 556–570 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  129. Faruque, F. S. et al. The impact of preventive screening resource distribution on geographic and population-based disparities in colorectal cancer in Mississippi. BMC Res. Notes 8, 423 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  130. Rawl, S. M., Menon, U., Burness, A. & Breslau, E. S. Interventions to promote colorectal cancer screening: an integrative review. Nurs. Outlook 60, 172–181.e13 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  131. Fedewa, S. A. et al. Racial and ethnic disparities in interval colorectal cancer incidence: a population-based cohort study. Ann. Intern. Med. 166, 857–866 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  132. Mohl, J. T. et al. Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017–2020. JAMA Netw. Open 6, e2251384 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  133. Kominski, G. F., Nonzee, N. J. & Sorensen, A. The Affordable Care Act’s impacts on access to insurance and health care for low-income populations. Annu. Rev. Public Health 38, 489–505 (2017).

    Article  PubMed  Google Scholar 

  134. Xu, M. R. et al. Impact of the Affordable Care Act on colorectal cancer outcomes: a systematic review. Am. J. Prev. Med. 58, 596–603 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  135. Korshak, L. et al. National Veteran Health Equity Report: Colorectal Cancer Screening Information Brief (Veterans Health Administration, 2021).

  136. Doubeni, C. A., Selby, K. & Levin, T. R. Disparities in preventable mortality from colorectal cancer: are they the result of structural racism? Gastroenterology 160, 1022–1025 (2021).

    Article  PubMed  Google Scholar 

  137. Nelson, A. R. Unequal treatment: report of the Institute of Medicine on racial and ethnic disparities in healthcare. Ann. Thorac. Surg. 76, S1377–S1381 (2003).

    Article  PubMed  Google Scholar 

  138. Bonjer, H. J. et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N. Engl. J. Med. 372, 1324–1332 (2015).

    Article  CAS  PubMed  Google Scholar 

  139. Fleshman, J. et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann. Surg. 246, 655–664 (2007).

    Article  PubMed  Google Scholar 

  140. Jiang, W. Z. et al. Short-term outcomes of laparoscopy-assisted vs open surgery for patients with low rectal cancer: the LASRE randomized clinical trial. JAMA Oncol. 8, 1607–1615 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  141. Theophilus, M., Platell, C. & Spilsbury, K. Long-term survival following laparoscopic and open colectomy for colon cancer: a meta-analysis of randomized controlled trials. Colorectal Dis. 16, O75–O81 (2014).

    Article  CAS  PubMed  Google Scholar 

  142. Colon Cancer Laparoscopic or Open Resection Study Group Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 10, 44–52 (2009).

    Article  PubMed  Google Scholar 

  143. Bliton, J. N., Parides, M., Muscarella, P., Papalezova, K. T. & In, H. Understanding racial disparities in gastrointestinal cancer outcomes: lack of surgery contributes to lower survival in African American patients. Cancer Epidemiol. Biomark. Prev. 30, 529–538 (2021).

    Article  Google Scholar 

  144. Ahuja, V. et al. Racial disparities in complications following elective colon cancer resection: impact of laparoscopic versus robotic approaches. Am. J. Surg. 227, 85–89 (2024).

    Article  PubMed  Google Scholar 

  145. Ahmed, F. A. et al. Disparities in treatment and survival for patients with isolated colorectal liver metastases. Surgery 172, 1629–1635 (2022).

    Article  PubMed  Google Scholar 

  146. Andre, T. et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350, 2343–2351 (2004).

    Article  CAS  PubMed  Google Scholar 

  147. Hu, H. et al. Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase III OPTICAL trial. J. Clin. Oncol. 42, 2978–2988 (2024).

    Article  CAS  PubMed  Google Scholar 

  148. Liang, Z. et al. The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: a systematic review and meta-analysis. Front. Oncol. 12, 1024345 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  149. Sauer, R. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351, 1731–1740 (2004).

    Article  CAS  PubMed  Google Scholar 

  150. Donnelly, M. et al. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. Br. J. Surg. 110, 1316–1330 (2023).

    Article  PubMed  Google Scholar 

  151. Kasi, A. et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw. Open 3, e2030097 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  152. Chan, M., Rajasekar, G., Arnow, K. D., Wagner, T. H. & Dawes, A. J. Racial and ethnic disparities in access to total neoadjuvant therapy for rectal cancer. Surgery 176, 1058–1064 (2024).

    Article  PubMed  Google Scholar 

  153. Le, H., Ziogas, A., Lipkin, S. M. & Zell, J. A. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol. Biomark. Prev. 17, 1950–1962 (2008).

    Article  Google Scholar 

  154. Vassantachart, A., Marietta, M., Mehta, S., Lin, E. & Bian, S. X. Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study. J. Gastrointest. Oncol. 13, 2922–2937 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  155. Cheung, W. Y., Neville, B. A. & Earle, C. C. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for stage II and III rectal cancer. Dis. Colon Rectum 52, 1054–1064 (2009).

    Article  PubMed  Google Scholar 

  156. Andre, T. et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N. Engl. J. Med. 383, 2207–2218 (2020).

    Article  CAS  PubMed  Google Scholar 

  157. Kopetz, S. et al. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N. Engl. J. Med. 381, 1632–1643 (2019).

    Article  CAS  PubMed  Google Scholar 

  158. Van Cutsem, E. et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 360, 1408–1417 (2009).

    Article  PubMed  Google Scholar 

  159. Manz, C. R. et al. Association of Oncologist participation in Medicare’s Oncology Care Model with patient receipt of novel cancer therapies. JAMA Netw. Open 5, e2234161 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  160. Roberts, T. J. et al. Practice-level variation in molecular testing and use of targeted therapy for patients with non-small cell lung cancer and colorectal cancer. JAMA Netw. Open 6, e2310809 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  161. Yoon, H. H. et al. Racial differences in BRAF/KRAS mutation rates and survival in stage III colon cancer patients. J. Natl Cancer Inst. 107, djv186 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  162. Yousef, M. et al. Molecular, socioeconomic, and clinical factors affecting racial and ethnic disparities in colorectal cancer survival. JAMA Oncol. 10, 1519–1529 (2024).

    Article  PubMed  Google Scholar 

  163. Bruno, D. S., Hess, L. M., Li, X., Su, E. W. & Patel, M. Disparities in biomarker testing and clinical trial enrollment among patients with lung, breast, or colorectal cancers in the United States. JCO Precis. Oncol. 6, e2100427 (2022).

    Article  PubMed  Google Scholar 

  164. Dharwadkar, P. et al. Racial and ethnic disparities in germline genetic testing of patients with young-onset colorectal cancer. Clin. Gastroenterol. Hepatol. 20, 353–361.e3 (2022).

    Article  CAS  PubMed  Google Scholar 

  165. Lawler, T., Parlato, L. & Warren Andersen, S. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review. Cancer Causes Control. 35, 223–239 (2024).

    PubMed  Google Scholar 

  166. Best, A. L. et al. Structural racism and cancer: calls to action for cancer researchers to address racial/ethnic cancer inequity in the United States. Cancer Epidemiol. Biomark. Prev. 31, 1243–1246 (2022).

    Article  CAS  Google Scholar 

  167. Trendowski, M. R. et al. Correlates of health-related quality of life in African Americans diagnosed with cancer: a review of survivorship studies and the Detroit research on cancer survivors cohort. Cancer Metastasis Rev. 43, 1373–1384 (2024).

    Article  PubMed  Google Scholar 

  168. Rabeneck, L., Souchek, J. & El-Serag, H. B. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am. J. Gastroenterol. 98, 1186–1192 (2003).

    Article  PubMed  Google Scholar 

  169. McCollum, A. D. et al. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J. Natl Cancer Inst. 94, 1160–1167 (2002).

    Article  CAS  PubMed  Google Scholar 

  170. Beaver, K., Bogg, J. & Luker, K. A. Decision-making role preferences and information needs: a comparison of colorectal and breast cancer. Health Expect. 2, 266–276 (1999).

    Article  PubMed  PubMed Central  Google Scholar 

  171. Beaver, K. et al. Colorectal cancer patients’ attitudes towards involvement in decision making. Health Expect. 12, 27–37 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  172. Beaver, K. et al. Patient participation in decision making: views of health professionals caring for people with colorectal cancer. J. Clin. Nurs. 16, 725–733 (2007).

    Article  PubMed  Google Scholar 

  173. Beaver, K. et al. Exploring the decision-making preferences of people with colorectal cancer. Health Expect. 8, 103–113 (2005).

    Article  PubMed  PubMed Central  Google Scholar 

  174. Berry, J. et al. Examining racial disparities in colorectal cancer care. J. Psychosoc. Oncol. 27, 59–83 (2009).

    Article  PubMed  Google Scholar 

  175. Berry, J. et al. A black–white comparison of the quality of stage-specific colon cancer treatment. Cancer 116, 713–722 (2010).

    Article  PubMed  Google Scholar 

  176. Busch, E. L., Martin, C., DeWalt, D. A. & Sandler, R. S. Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control. 22, 95–101 (2015).

    Article  PubMed  Google Scholar 

  177. Chagpar, R. et al. Adherence to stage-specific treatment guidelines for patients with colon cancer. J. Clin. Oncol. 30, 972–979 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  178. Cranley, N. M., Curbow, B., George, T. J. Jr. & Christie, J. Influential factors on treatment decision making among patients with colorectal cancer: a scoping review. Support. Care Cancer 25, 2943–2951 (2017).

    PubMed  Google Scholar 

  179. Javier-DesLoges, J. et al. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials. Cancer 128, 770–777 (2022).

    Article  PubMed  Google Scholar 

  180. Pittell, H. et al. Racial and ethnic inequities in US oncology clinical trial participation from 2017 to 2022. JAMA Netw. Open 6, e2322515 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  181. Coughlin, S. E. et al. Multigene panel testing yields high rates of clinically actionable variants among patients with colorectal cancer. JCO Precis. Oncol. 6, e2200517 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  182. Kupfer, S. S. et al. Genetic heterogeneity in colorectal cancer associations between African and European Americans. Gastroenterology 139, 1677–1685.e8 (2010).

    Article  CAS  PubMed  Google Scholar 

  183. Kupfer, S. S. et al. Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European Americans. Carcinogenesis 35, 2025–2030 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  184. Holowatyj, A. N. et al. Racial/ethnic and sex differences in somatic cancer gene mutations among patients with early-onset colorectal cancer. Cancer Discov. 13, 570–579 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  185. Rhead, B. et al. Association of genetic ancestry with molecular tumor profiles in colorectal cancer. Genome Med. 16, 99 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  186. Guda, K. et al. Novel recurrently mutated genes in African American colon cancers. Proc. Natl Acad. Sci. USA 112, 1149–1154 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  187. Jovov, B. et al. Differential gene expression between African American and European American colorectal cancer patients. PLoS ONE 7, e30168 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  188. Devall, M. et al. Racial disparities in epigenetic aging of the right vs left colon. J. Natl Cancer Inst. 113, 1779–1782 (2021).

    Article  PubMed  Google Scholar 

  189. Liang, P. S., Williams, J. L., Dominitz, J. A., Corley, D. A. & Zauber, A. G. Age-stratified prevalence and predictors of neoplasia among U.S. adults undergoing screening colonoscopy in a national endoscopy registry. Gastroenterology 163, 742–753.e4 (2022).

    Article  PubMed  Google Scholar 

  190. Corley, D. A. et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin. Gastroenterol. Hepatol. 11, 172–180 (2013).

    Article  PubMed  Google Scholar 

  191. Jackson, C. S. & Vega, K. J. Higher prevalence of proximal colon polyps and villous histology in African-Americans undergoing colonoscopy at a single equal access center. J. Gastrointest. Oncol. 6, 638–643 (2015).

    PubMed  PubMed Central  Google Scholar 

  192. Wallace, K. et al. Race and prevalence of large bowel polyps among the low-income and uninsured in South Carolina. Dig. Dis. Sci. 61, 265–272 (2016).

    Article  PubMed  Google Scholar 

  193. Lieberman, D. A. et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 300, 1417–1422 (2008).

    Article  CAS  PubMed  Google Scholar 

  194. Laiyemo, A. O. et al. Occurrence of distal colorectal neoplasia among Whites and Blacks following negative flexible sigmoidoscopy: an analysis of PLCO trial. J. Gen. Intern. Med. 30, 1447–1453 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  195. Allford, A., Qureshi, N., Barwell, J., Lewis, C. & Kai, J. What hinders minority ethnic access to cancer genetics services and what may help? Eur. J. Hum. Genet. 22, 866–874 (2014).

    Article  PubMed  Google Scholar 

  196. Lin, J., Qiu, M., Xu, R. & Dobs, A. S. Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Oncotarget 6, 33935–33943 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  197. Shavers, V. L. Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J. Natl Med. Assoc. 99, 733–748 (2007).

    PubMed  PubMed Central  Google Scholar 

  198. Azar, I., Esfandiarifard, S., Sinai, P. & Mehdi, S. Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009. Cancer 124, 2858 (2018).

    Article  PubMed  Google Scholar 

  199. Dietrich, A. J. et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann. Intern. Med. 144, 563–571 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  200. Itzkowitz, S. H. et al. New York citywide colon cancer control coalition: a public health effort to increase colon cancer screening and address health disparities. Cancer 122, 269–277 (2016).

    Article  PubMed  Google Scholar 

  201. Weng, O. Colorectal cancer prevention: timely colonoscopy screening among New Yorkers ages 50 and older. NYC Vital Signs 18, 1–4 (2020).

    Google Scholar 

  202. Delaware Cancer Consortium. Delaware past reports available from Cancer Consortium. Delaware.gov https://dhss.delaware.gov/dhss/dph/dpc/consortium.html (2008).

  203. Delaware Health and Social Services. Testing for breast, cervical, prostate, lung, and colorectal cancer. Delaware.gov https://dhss.delaware.gov/dhss/dph/dpc/sfl.html (2025).

  204. Delaware Health and Social Services. Cancer treatment program provides financial help for uninsured patients. Delaware.gov https://dhss.delaware.gov/dhss/dph/dpc/catreatment.html (2025).

  205. Obrochta, C. A., Murphy, J. D., Tsou, M. H. & Thompson, C. A. Disentangling racial, ethnic, and socioeconomic disparities in treatment for colorectal cancer. Cancer Epidemiol. Biomark. Prev. 30, 1546–1553 (2021).

    Article  Google Scholar 

  206. Abdel-Rahman, O. Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. Int. J. Clin. Oncol. 24, 1582–1587 (2019).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank K. Heskett and J. J. Tuan for their assistance with the literature search for this article. The authors also thank E. Schafer for statistical support. This material is the result of work supported in part by resources from the Veterans Health Administration. The content is solely the responsibility of the authors and does not represent the views of the Department of Veterans Affairs or the US Government. F.P.M. is supported by National Cancer Institute grant R01CA271034 (to F.P.M.), Department of Veterans Affairs Health Services Research and Development grant 10I01HX003605 (to S.G. and F.P.M.), Stand up to Cancer, and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Ablon Scholars Program. W.T.M. is supported by National Institutes of Health grant KL2 TR001444 (to W.T.M.), Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program, and Bristol Myers Squibb Robert A. Winn Career Development Award. A.J. is supported by Intramural Research, American Cancer Society. S.G. is supported by National Cancer Institute grant R37 MERIT CA222866 (to S.G.) and Department of Veterans Affairs Health Services Research and Development grants 5I01HX001574 (to S.G.) and 1I01HX003605 (to F.P.M. and S.G.).

Author information

Authors and Affiliations

Authors

Contributions

The authors contributed equally to all aspects of the article.

Corresponding author

Correspondence to Folasade P. May.

Ethics declarations

Competing interests

F.P.M. is a medical adviser for Exact Sciences, Medtronic, Freenome, Geneoscopy, Guardant Health, InterVenn and Natura. S.G. is a medical adviser for Geneoscopy, Guardant Health, Universal Diagnostics, InterVenn and CellMax; and has received research support from Freenome and Exact Sciences. The other authors declare no competing interests.

Peer review

Peer review information

Nature Reviews Gastroenterology & Hepatology thanks Jonathan Laryea and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Related links

Delaware Cancer Control: https://dhss.delaware.gov/dph/dpc/cancer.html

Kaiser Permanente Northern California: https://about.kaiserpermanente.org

National Cancer Institute Cancer trends progress report: https://progressreport.cancer.gov

New York Citywide Colon Cancer Control Coalition: https://www.nyc.gov/site/doh/providers/resources/citywide-colon-cancer-control-coalition.page

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

May, F.P., Mehtsun, W.T., Jemal, A. et al. Black–White disparities across the colorectal cancer care continuum in the USA. Nat Rev Gastroenterol Hepatol 22, 603–618 (2025). https://doi.org/10.1038/s41575-025-01087-3

Download citation

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41575-025-01087-3

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing